Exane Derivatives Merck & Co., Inc. Transaction History

Exane Derivatives

$157 Million
Q2 2022

A detailed history of Exane Derivatives transactions in Merck & Co., Inc. stock. As of the latest transaction made, Exane Derivatives holds 64,879 shares of MRK stock, worth $6.69 Million. This represents 3.78% of its overall portfolio holdings.

Number of Shares

64,879

Previous 67,894 4.44%

Holding current value

$6.69 Million

Previous $5.57 Million 6.19%

% of portfolio

3.78%

Previous 1.72%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$83.49 - $94.64 $251,722 - $285,339	-3,015 Reduced 4.44%	64,879 $5.92 Million
Q1 2022 Apr 22, 2022	BUY	$73.51 - $82.4 $768,620 - $861,574	10,456 Added 18.2%	67,894 $5.57 Million
Q4 2021 Jan 28, 2022	SELL	$72.28 - $90.54 $360,460 - $451,522	-4,987 Reduced 7.99%	57,438 $4.4 Million
Q3 2021 Oct 26, 2021	BUY	$71.68 - $78.83 $641,320 - $705,292	8,947 Added 16.73%	62,425 $4.69 Million
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $143,151 - $158,339	2,036 Added 3.96%	53,478 $4.16 Million
Q1 2021 Apr 30, 2021	BUY	$68.86 - $81.11 $262,081 - $308,704	3,806 Added 7.99%	51,442 $3.78 Million
Q4 2020 Jan 27, 2021	SELL	$71.77 - $79.65 $1.94 Million - $2.15 Million	-27,043 Reduced 36.21%	47,636 $3.72 Million
Q3 2020 Oct 06, 2020	BUY	$73.18 - $82.95 $1.5 Million - $1.7 Million	20,551 Added 37.97%	74,679 $5.91 Million
Q2 2020 Jul 10, 2020	SELL	$70.42 - $80.13 $2.78 Million - $3.16 Million	-39,418 Reduced 42.14%	54,128 $3.99 Million
Q1 2020 Apr 17, 2020	BUY	$63.36 - $87.82 $2.46 Million - $3.41 Million	38,864 Added 71.07%	93,546 $6.87 Million
Q4 2019 Jan 22, 2020	BUY	$77.58 - $87.54 $122,576 - $138,313	1,580 Added 2.98%	54,682 $4.75 Million
Q3 2019 Oct 15, 2019	BUY	$76.08 - $82.93 $91,448 - $99,681	1,202 Added 2.32%	53,102 $4.27 Million
Q2 2019 Jul 12, 2019	SELL	$69.84 - $81.59 $232,986 - $272,184	-3,336 Reduced 6.04%	51,900 $0
Q1 2019 Apr 24, 2019	BUY	$69.58 - $79.36 $645,284 - $735,984	9,274 Added 20.18%	55,236 $0
Q4 2018 Jan 31, 2019	SELL	$65.24 - $75.71 $609,667 - $707,509	-9,345 Reduced 16.9%	45,962 $3.35 Million
Q3 2018 Oct 24, 2018	BUY	$57.69 - $67.84 $2.63 Million - $3.1 Million	45,662 Added 473.43%	55,307 $0
Q2 2018 Jul 19, 2018	BUY	$50.83 - $59.72 $490,255 - $575,999	9,645 New	9,645 $0

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account

Exane Derivatives Merck & Co., Inc. Transaction History